6. The clinical trial process in new drug development

Capsules of CRN00808 in trial for the treatment of Acromegaly and Neuroendocrine Tumors

Dr. Alan Krasner, Chief Medical Officer, and Dr. Chris Cook, Medical Director, Endocrinology at Crinetics Pharmaceuticals offer an in-depth look at clinical studies.  In this podcast, we cover a promising molecule – CRNOO808 – under development for acromegaly and neuroendocrine tumors (NET’s), and another hopeful new drug for pediatric congenital hyperinsulinism.  They talked about the challenges, their hopes for new therapeutic strategies, the complexities of their work, and how patients can get involved with industry and government regulators to improve these drugs and therapies.   Click here to listen to more podcasts.

 

Photo:  J D Faccinetti’s hand.

© 2020, Pituitary World News. All rights reserved.

LEAVE A REPLY

Please enter your comment!
Please enter your name here